William Blair Initiates Coverage On Arcus Biosciences with Outperform Rating

10/16/2026
Impact: 70
Healthcare

William Blair analyst Alethia Young has initiated coverage on Arcus Biosciences (NYSE: RCUS) with an Outperform rating. This marks a positive outlook for the company in the market.

AI summary, not financial advice

Share: